SPATA31C1: A Potential Drug Target for Neurological Disorders

Target Name: SPATA31C1

NCBI ID: G441452

SPATA31C1

SPATA31C1: A Potential Drug Target for Neurological Disorders

SPATA31C1 (S31C1_HUMAN) is a protein that is expressed in various tissues of the human body, including the nervous system, endocrine system, and immune system. It is a key regulator of cellular processes that are involved in the development and maintenance of tissues, including brain and nervous system cells.

SPATA31C1 has been identified as a potential drug target due to its involvement in several neurological and psychiatric disorders. It has been shown to be involved in the development and progression of several neurological disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

In addition to its involvement in neurological disorders, SPATA31C1 has also been linked to a number of other diseases and disorders. For example, it has been shown to be involved in the development and progression of several cardiovascular diseases, including heart failure and hypertension. It has also been linked to the development of certain cancers, including breast and ovarian cancer.

SPATA31C1 is a transmembrane protein that is expressed in various tissues of the human body. It is composed of a extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain of SPATA31C1 is involved in its ability to interact with other proteins, while the transmembrane domain is responsible for the transportation of the protein across the membrane of the cell. The intracellular domain is responsible for the regulation of the protein's activity within the cell.

SPATA31C1 is involved in a number of cellular processes that are important for the development and maintenance of tissues. It has been shown to be involved in the regulation of cell growth, cell differentiation, and cell survival. It is also involved in the regulation of cellular signaling pathways, including the TGF-β pathway.

SPATA31C1 is a protein that has been shown to be involved in the development and progression of several neurological and psychiatric disorders. It is a potential drug target that could be used to treat a variety of neurodegenerative diseases. Further research is needed to fully understand the role of SPATA31C1 in neurological and psychiatric disorders, as well as its potential as a drug target.

Protein Name: SPATA31 Subfamily C Member 1

Functions: May play a role in spermatogenesis

The "SPATA31C1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPATA31C1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets